Molecular Medicine
Molecular Medicine is a wide field comprehends the ordinary body working and infection pathogenesis at the sub-atomic level by utilizing physical, synthetic, natural and restorative strategies with the objective to create sub-atomic intercessions to right them. Atomic prescription is the use of Molecular Biology and Molecular Genetics to the comprehension of human wellbeing and malady. It plans to see how wellbeing is kept up and the starting points and components of human maladies. The sub-atomic pharmaceutical point of view stresses cell and sub-atomic marvels and mediations instead of the past applied and observational spotlight on patients and their organs.
The worldwide Molecular Medicine was esteemed at $2.9 billion in 2012 and is ready to reach $7.5 billion by 2017 at a CAGR of 20.9%. The development of the Molecular Medicine is driven by lessening in expense of DNA sequencing, expanding government activities and subsidizing, and developing use Molecular Medicine in medication revelation and biomarkers improvement forms. It is normal that the business sector will offer open doors for Molecular Medicine arrangements makers with the presentation and appropriation of up and coming advancements, for example, nanopore sequencing and distributed computing.
Related Conference of Molecular Medicine
20th World Congress on Tissue Engineering Regenerative Medicine and Stem Cell Research
18th International Conference on Human Genomics and Genomic Medicine
16th International Conference on Human Genetics and Genetic Diseases
19th International Conference on Genomics & Pharmacogenomics
Molecular Medicine Conference Speakers
Recommended Sessions
- Bioprocess Engineering and Biomarkers
- Cancer Genomics
- Chromosomal Abnormalities
- Clinical applications and diagnostics
- Cytogenetics
- Ecogenomics
- Evolution of Novel Genes
- Gene Expression, Regulation And Cloning
- Gene Mapping
- Genetic counseling
- Genetic Disorders Tests
- Genetic engineering techniques
- Genetic Testing Market
- Genetically modified organisms
- Genomic analysis
- Genomic data
- Genomic medicine
- Global DNA and Gene Chip (Microarrays)
- Medical genomics
- Microbial genetics
- Molecular Medicine
- Next generation sequencing
- Novel medical Devices
- Pedigree Methods
- Personalised genomics
- Pharmacogenetics
- Polygenic inheritance
- Prenatal diagnosis
- Reprogenetics
- Teratogenesis and their effects
- Tissue culture techniques
- Tissue Engineering and Regeneration
- Transgenic Research
- Tumor Markers
Related Journals
Are you interested in
- Achieving efficient delivery and editing - CRISPR 2025 (Italy)
- Artificial Intelligence and Computational Biology in Regenerative Medicine - Stemgen 2026 (France)
- Bioinformatics - HUMAN GENOME 2025 (France)
- Biomaterials and Nanotechnology in Regenerative Medicine - Stemgen 2026 (France)
- Cancer and stem cells - CRISPR 2025 (Italy)
- Cancer Genomics - HUMAN GENOME 2025 (France)
- Cancer Stem Cells and Oncology - Stemgen 2026 (France)
- Cardiovascular Regeneration - Stemgen 2026 (France)
- Clinical Trials and Translational Stem Cell Research - Stemgen 2026 (France)
- Cognitive Computing - HUMAN GENOME 2025 (France)
- Computational Biology - HUMAN GENOME 2025 (France)
- CRISPR technologies and society - CRISPR 2025 (Italy)
- CRISPR technologies beyond genome editing and gene regulation - CRISPR 2025 (Italy)
- Drug Detection & Development in Bioinformatics - HUMAN GENOME 2025 (France)
- Emergency Medicine - HUMAN GENOME 2025 (France)
- Epigenetics Biomarkers - HUMAN GENOME 2025 (France)
- Ethical, Legal, and Social Implications in Stem Cell Research - Stemgen 2026 (France)
- Future Trends: Organoids, Bioengineering, and Next-Generation Therapies - Stemgen 2026 (France)
- Gene Editing and CRISPR Technologies - Stemgen 2026 (France)
- Genetically Modified Organisms - HUMAN GENOME 2025 (France)
- Genome editing and gene regulation in human health - CRISPR 2025 (Italy)
- Genome editing and gene regulation in industrial bacterial biotechnology - CRISPR 2025 (Italy)
- Genome editing and gene regulation in industrial eukaryotic biotechnology - CRISPR 2025 (Italy)
- Genome Editing Methods and Novel Tools - CRISPR 2025 (Italy)
- Genome Mapping - HUMAN GENOME 2025 (France)
- Genomic Approach to Drug Discovery - HUMAN GENOME 2025 (France)
- Genomic Information in Medicine - HUMAN GENOME 2025 (France)
- Genomic Vaccination - HUMAN GENOME 2025 (France)
- Genomics - HUMAN GENOME 2025 (France)
- Horizons of CRISPR biology - CRISPR 2025 (Italy)
- Human Gene Therapy - HUMAN GENOME 2025 (France)
- Human Genetics - HUMAN GENOME 2025 (France)
- Induced Pluripotent Stem Cells (iPSCs) and Reprogramming - Stemgen 2026 (France)
- Infectious Diseases - HUMAN GENOME 2025 (France)
- Medicine Genomics - HUMAN GENOME 2025 (France)
- Mesenchymal Stem Cells (MSCs) in Therapy - Stemgen 2026 (France)
- Personalized Medicine - HUMAN GENOME 2025 (France)
- Pharma Genomics & Pharma Informatics - HUMAN GENOME 2025 (France)
- Plant and Animal Biotechnology - CRISPR 2025 (Italy)
- Preimplantation Genetic Diagnosis - HUMAN GENOME 2025 (France)
- Regenerative Dentistry and Craniofacial Applications - Stemgen 2026 (France)
- Regenerative Medicine and Tissue Engineering - Stemgen 2026 (France)
- Stem Cell Banking and Cryopreservation - Stemgen 2026 (France)
- Stem Cell Biology and Cellular Mechanisms - Stemgen 2026 (France)
- Stem Cells in Neurological and Neurodegenerative Disorders - Stemgen 2026 (France)
- Structural Biology and Bioinformatics - CRISPR 2025 (Italy)
- Therapeutic Genome Editing - CRISPR 2025 (Italy)